1997b What America’s Users Spend on Illegal Drugs, 1988–1995. Washington, DC: U.S. Government Printing Office.
Reuter, P. 1997 Drug use measures: What are they really telling us? National Institute of Justice Journal, April 1999.
1993 Prevalence estimation and policy formulation. Journal of Drug Issues 23(2):167– 184.
Rhodes, W., R.Hyatt, and P.Scheiman 1994 The price of cocaine, heroin and marijuana 1981–1993. Journal of Drug Issues 24:383– 402.
Rydell, C.P., and S.S.Everingham 1994 Controlling Cocaine: Report prepared for the Office of National Drug Control Policy and the U.S. Army. Santa Monica, CA: RAND.
Saffer, H., and Chaloupka, F. 1995 The Demand for Illicit Drugs. Working paper 5238. Cambridge, MA: National Bureau of Economic Research.
Sloboda, Z., and N.Kozel 1999 Frontline Surveillance: The Community Epidemiology Work Group on Drug Abuse. In Drug Abuse: Origins & Interventions, M.Glantz and C.Hartel, editors. Washington, DC: American Psychological Association Press.
Steel, E., and H.W.Haverkos 1992 Epidemiologic studies of HIV/AIDS and drug abuse. American Journal of Drug Alcohol Abuse 18(2):167–175.
Substance Abuse and Mental Health Services Administration 1999 Year-End 1998 Emergency Department Data from the Drug Abuse Warning Network. Washington, DC: U.S. Department of Health and Human Services.
1997 Substance Abuse in State and Metropolitan Areas: Model Based Estimates from the 1991– 1993 National Household Surveys on Drug Abuse Summary Report. Washington, U.S. DC: Department of Health and Human Services.
U.S. General Accounting Office 1993 Drug Use Measurement: Strengths, Limitations, and Recommendations for Improvement. GAO/PEMD-93–18. Washington, DC: U.S. General Accounting Office.
Wish, E.D., and B.A.Gropper 1990 Drug testing by the criminal justice system: Method, research, and applications. Pp. 321–339 in J.Q.Wilson and M.Tonry, editors, Drugs and Crime:. Chicago: University of Chicago Press.
Yuan, Y., and J.P.Caulkins 1998 The effects of variation in high-level domestic drug enforcement on variation in drug prices. Socio-Economic Planning Sciences 32:265–276.